Skip to main content
Log in

Relationship between histological subtypes and clinical characteristics at presentation and outcome in biopsy-proven temporal arteritis

Identification of a relatively benign subgroup

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Temporal arteritis (TA) may offer major complications, whilst high dosage of prednisone may result in serious side effects. We tried to identify a subgroup of TA, which can be treated with a lower dosage of prednisone. Retrospectively, clinical and laboratory data were studied at presentation, as well as the outcome in 44 consecutive patients with biopsy-proven temporal arteritis. These data were related to three particular histological subgroups, (a) classical giant cell arteritis, (b) atypical arteritis, and (c) ‘healed arteritis’, defined according to Allsop and Gallagher (The American Journal of Surgical Pathology 5:317–332, 1981). At presentation in subgroup c, erythrocyte sedimentation rate was lower and the level of haemoglobin was higher than in the other two subgroups. During follow-up in the healed arteritis group, reactivation, recurrence, or early death were not observed, whilst prednisone dosage after 2 and 3 years was lower compared to subgroup b. Major complications (permanent blindness and cerebrovascular accident) were only observed in subgroups a and b. We believe that the healed arteritis subgroup represents a relatively benign subgroup with a mild clinical presentation and a good prognosis. Therefore, a much lower initial prednisone dosage (15 mg/day) is suggested for patients in subgroup c than in the other two subgroups (40–60 mg/day).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Allsop CJ, Gallagher PJ (1981) Temporal artery biopsy in giant-cell arteritis. Am J Surg Pathol 5:317–332

    Article  PubMed  CAS  Google Scholar 

  2. Evans JM, Hunder GG (2000) Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am 26(3):493–515

    Article  PubMed  CAS  Google Scholar 

  3. Hunder CG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128

    Article  PubMed  CAS  Google Scholar 

  4. Healy LA, Parker F, Wilske KR (1971) Polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 14:138–141

    Article  Google Scholar 

  5. Chmelewski WL, McKnight KM, Agudelo CA, Wise CM (1992) Presenting features and outcomes in patients undergoing temporal artery biopsy. A review of 98 patients. Arch Intern Med 152:1690–1995

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. J. ter Borg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

ter Borg, E.J., Haanen, H.C.M. & Seldenrijk, C.A. Relationship between histological subtypes and clinical characteristics at presentation and outcome in biopsy-proven temporal arteritis. Clin Rheumatol 26, 529–532 (2007). https://doi.org/10.1007/s10067-006-0332-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0332-0

Keywords

Navigation